PMGC Holdings ELAB
NASDAQ ELAB
$6.66 +0.56 (+9.18%)
At close: Aug 21, 2026 · 4:00 PM EDT

PMGC Holdings (ELAB) Other Non Operating Income (2022 - 2026)

PMGC Holdings (ELAB) posted Other Non Operating Income of $1729.0 for Q1 2026, up 100.37% sequentially from -$467186.0 in Q4 2025.

PMGC Holdings (ELAB) Other Non Operating Income (2022 - 2026) Analysis & Trends

PMGC Holdings has reported Other Non Operating Income for 5 years, with the latest figure at $1729.0 in Q1 2026.

  • Quarterly Other Non Operating Income changed N/A year-over-year to $1729.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$511543.0 (changed N/A YoY) and the FY2025 annual result came in at $21613.0, up 469.71% from the prior year.
  • Other Non Operating Income climbed to $1729.0 in Q1 2026 per ELAB's latest filing, from -$467186.0 in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $1.3 million in Q4 2022 and troughed at -$467186.0 in Q4 2025.
  • A 5-year average of $93559.0 and a median of -$244.0 in 2024 frame the typical range for Other Non Operating Income.
  • The sharpest annual moves came in 2024 and 2025: Other Non Operating Income jumped 13506.56% in 2024, then slumped 1014.68% in 2025.
  • Over 5 years, Other Non Operating Income stood at $1.3 million in 2022, then tumbled by 106.94% to -$91489.0 in 2023, then surged by 54.19% to -$41912.0 in 2024, then plunged by 1014.68% to -$467186.0 in 2025, then surged by 100.37% to $1729.0 in 2026.
  • According to Business Quant data, Other Non Operating Income over the past three periods registered $1729.0, -$467186.0, and -$4174.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 PMGC Holdings 31.22 Mn 12.43 Mn 385,691.00

Historic Data

Download Data
DateValue
Mar 31, 2026 1,729.00
Dec 31, 2025 -467,186.00
Sep 30, 2025 -4,174.00
Dec 31, 2024 -41,912.00
Sep 30, 2024 1,343.00
Jun 30, 2024 -244.00
Mar 31, 2024 34,723.00
Dec 31, 2023 -91,489.00
Sep 30, 2023 3,113.00
Jun 30, 2023 -2,374.00
Mar 31, 2023 -259.00
Dec 31, 2022 1.32 Mn
Sep 30, 2022 465,000.00